Table 1.

Description of New Vaccine Surveillance Network Rotavirus Cases and Controls in RV5 and RV1 Analytical Datasets

Variables	RV5 Analysis				P Value	RV1 Analysis				P Value
	Rotavirus Cases (n = 402)		Controls (n = 2559)			Rotavirus Cases (n = 100)		Controls (n = 804)
	n	Percent	n	Percent		n	Percent	n	Percent
Age (in months)					<.001					<.001
Median	35	Range (8–82)	26	Range (8–89)		24	Range (8–56)	18	Range (8–62)
Gender					.041					.157
Male	203	50.5	1432	59.7		47	47.0	438	54.5
Female	199	49.5	1127	48.8		53	53.0	366	45.5
Race					.407					.419
White	253	62.9	1528	59.7		39	39.0	269	33.5
Black	89	22.1	647	25.3		40	40.0	391	48.6
Other	60	14.9	384	15.0		21	21.0	144	17.9
Ethnicity					.024					.775
Hispanic	152	37.8	1115	43.6		21	21.0	191	23.8
Non-Hispanic	248	61.7	1441	56.3		79	79.0	612	76.1
Other/Unknown	2	0.5	3	0.1		0	0.0	1	0.1
Insurance					<.001					.018
Private	1268	31.8	555	21.6		19	19.0	88	10.9
Public/None	274	68.2	2006	78.4		81	81.0	716	89.1
Clinical Setting					.038					.303
Inpatient	66	16.4	324	12.7		19	19.0	121	15.0
ED	336	83.6	2235	87.3		81	81.0	683	85.0
Season					<.001					<.001
2012	77	19.1	1105	43.2		15	15.0	330	41.0
2013	325	80.9	1454	56.8		85	85.0	474	59.0
NVSN Site					<.001					<.001
Oakland	58	14.4	258	10.1		20	20.0	54	6.7
Seattle	52	12.9	248	9.7		ф		ф
Kansas City	46	11.4	382	14.9		46	46.0	425	52.9
Houston	125	31.1	785	30.7		ф		ф
Nashville	79	19.7	543	21.2		ф		ф
Cincinnati	21	5.2	257	10.0		23	23.0	270	33.6
Rochester	21	5.2	86	3.4		11	11.0	55	6.8

ф = Insufficient observations.

Abbreviations: ED, emergency department; NVSN, New Vaccine Surveillance Network.